An improved procedure for the synthesis of vinylphosphonate-linked nucleic acids



Similar documents
UNIVERSITY OF PÉCS. Palladium-catalysed aminocarbonylation reactions of iodoarenes and iodoalkenes. Attila Takács

T3P Propane Phosphonic Acid Anhydride

EXPERIMENT 5: DIPEPTIDE RESEARCH PROJECT

1. COUPLING REAGENTS : Structure and acronyms

Applications of Organic Solvent Nanofiltration in the Process Development of Active Pharmaceutical Ingredients. Dominic Ormerod

A disaccharide is formed when a dehydration reaction joins two monosaccharides. This covalent bond is called a glycosidic linkage.

2. The number of different kinds of nucleotides present in any DNA molecule is A) four B) six C) two D) three

A novel method for the synthesis of peptides

Enzymes and Metabolism

Essentials of Real Time PCR. About Sequence Detection Chemistries

Nucleotides and Nucleic Acids

NO CALCULATORS OR CELL PHONES ALLOWED

Introduction to Proteins and Enzymes

Chemical Basis of Life Module A Anchor 2

Gene Silencing Oligos (GSOs) Third Generation Antisense

Cleavage of Cyclobutanols and Cyclobutanones

Disaccharides consist of two monosaccharide monomers covalently linked by a glycosidic bond. They function in sugar transport.

and its application in the synthesis of Nilotinib intermediate

How To Understand The Chemistry Of Organic Molecules

Guide to Reverse Phase SpinColumns Chromatography for Sample Prep

Methods of Grading S/N Style of grading Percentage Score 1 Attendance, class work and assignment 10 2 Test 20 3 Examination 70 Total 100

Combinatorial Chemistry and solid phase synthesis seminar and laboratory course

Supporting Information

Syllabus for MCB 3010/5001: Biochemistry Fall Semester 2011

2. True or False? The sequence of nucleotides in the human genome is 90.9% identical from one person to the next. False (it s 99.

Lecture 4 Enzymes Catalytic proteins. Enzymes. Enzymes 10/21/10. What enzymes do therefore is:

Properties of a molecule. Absolute configuration, Cahn-Ingold Prelog. Planar, axial, topological chirality and chirality at atoms other than carbon

Bio 102 Practice Problems Chromosomes and DNA Replication

Carboxylic Acid Derivatives and Nitriles

Mitsunobu Reaction ( )

Hamari Chemicals, Ltd.

Replication Study Guide

What happens to the food we eat? It gets broken down!

How many of you have checked out the web site on protein-dna interactions?

The Steps. 1. Transcription. 2. Transferal. 3. Translation

But in organic terms: Oxidation: loss of H 2 ; addition of O or O 2 ; addition of X 2 (halogens).

IMPURITIES IN NEW DRUG PRODUCTS

Your partner in immunology

Chapter 3 Molecules of Cells

Biochemistry of Cells

Stille, Suzuki, and Sonogashira Couplings Cross-Coupling reactions: catalyst R-X + R'-M

RNA & Protein Synthesis

ETHYL LAUROYL ARGINATE Chemical and Technical Assessment. Prepared by Yoko Kawamura, Ph.D. and Brian Whitehouse, Ph.D., for the 69 th JECFA

Chapter 8: Chemical Equations and Reactions

Chemical Bonds and Groups - Part 1

8/20/2012 H C OH H R. Proteins

Lecture 11 Enzymes: Kinetics

1. Molecular computation uses molecules to represent information and molecular processes to implement information processing.

Proteins and Nucleic Acids

Working with Hazardous Chemicals

DNA is found in all organisms from the smallest bacteria to humans. DNA has the same composition and structure in all organisms!

博 士 論 文 ( 要 約 ) A study on enzymatic synthesis of. stable cyclized peptides which. inhibit protein-protein interactions

The Molecules of Life - Overview. The Molecules of Life. The Molecules of Life. The Molecules of Life

Guidance for Industry


Integrating Bioinformatics, Medical Sciences and Drug Discovery

Catalysis by Enzymes. Enzyme A protein that acts as a catalyst for a biochemical reaction.

Chapter 5. The Structure and Function of Macromolecule s

DNA Sequencing Troubleshooting Guide

Translation Study Guide

1. A covalent bond between two atoms represents what kind of energy? a. Kinetic energy b. Potential energy c. Mechanical energy d.

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J10

VCE CHEMISTRY : UNIT 3 SAMPLE COURSE OUTLINE

PhD. Thesis. New types of heterogeneous palladium loaded catalysts (Synthesis and application) Attila Papp. Supervisor: Dr.

MASTERS OF PHILOSOPHY (M. PHIL.) BIOCHEMISTRY DETAILED SYLLABUS SESSION

Prentice Hall. Chemistry (Wilbraham) 2008, National Student Edition - South Carolina Teacher s Edition. High School. High School

2010 European Amino Acid Derivatives Product Line Strategy Award

Chemical reactions allow living things to grow, develop, reproduce, and adapt.

BIOLOGICAL MOLECULES OF LIFE

David W. C. MacMillan Career-in-Review. Sujun Wei BreslowGroup Columbia University September 28, 2007

COURSE TITLE COURSE DESCRIPTION

STRUCTURES OF NUCLEIC ACIDS

Study of the Thermal Behavior of Azidohetarenes with Differential Scanning Calorimetry

Lecture Overview. Hydrogen Bonds. Special Properties of Water Molecules. Universal Solvent. ph Scale Illustrated. special properties of water

1 General introduction

Application Note # LCMS-62 Walk-Up Ion Trap Mass Spectrometer System in a Multi-User Environment Using Compass OpenAccess Software

1) Technical informations. - a) How does it work? - b) Purification - c) Quality Control. 2) Standard synthesis

Problem Set 1 KEY

Chemical Literature. Chemical Abstracts Since Chemical Literature. Chemical Literature. Types of Scientific Literature

How To Understand The Chemistry Of A 2D Structure

DNA SPOOLING 1 ISOLATION OF DNA FROM ONION

Application Note. Separation of three monoclonal antibody variants using MCSGP. Summary

Chemistry Diagnostic Questions

From DNA to Protein. Proteins. Chapter 13. Prokaryotes and Eukaryotes. The Path From Genes to Proteins. All proteins consist of polypeptide chains

General Properties Protein Nature of Enzymes Folded Shape of Enzymes H-bonds complementary

Answer: 2. Uracil. Answer: 2. hydrogen bonds. Adenine, Cytosine and Guanine are found in both RNA and DNA.

13.2 Ribosomes & Protein Synthesis

Name Date Period. 2. When a molecule of double-stranded DNA undergoes replication, it results in

USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.

Lecture 26: Overview of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) structure

green B 1 ) into a single unit to model the substrate in this reaction. enzyme

The Synthesis of trans-dichlorobis(ethylenediamine)cobalt(iii) Chloride

experiment5 Understanding and applying the concept of limiting reagents. Learning how to perform a vacuum filtration.

Controlling Gold Nanoparticles with Atomic Precision: Synthesis and Structure Determination

Novel Method for Solid Phase Peptide Synthesis Using Microwave Energy

Introduction. Preparation of Template DNA

SPE and HPLC. Dr Iva Chianella Lecturer in Analytical Chemistry Cranfield Health +44 (0)

Transcription:

Tetrahedron Letters 41 (2000) 4513±4517 An improved procedure for the synthesis of vinylphosphonate-linked nucleic acids Sahar Abbas and Christopher J. Hayes* The School of Chemistry, The University of Nottingham, University Park, Nottingham NG7 2RD, UK Received 24 March 2000; accepted 20 April 2000 Abstract The synthesis of a range of 5 0 -deoxy-5 0 -methylidene phosphonate-containing thymidine dimers has been achieved using a palladium-catalysed cross coupling reaction as a key step. The optimised reaction conditions comprising of palladium acetate, 1,1 0 -bis(diphenylphosphino)ferrocene and propylene oxide in THF were found to couple a range of H-phosphonates and vinyl bromide 3 in fair to excellent yield. # 2000 Elsevier Science Ltd. All rights reserved. Keywords: antisense; palladium coupling; vinyl bromide; oligonucleotide; modi ed backbone. The potential to inhibit protein synthesis in vivo by binding a short `antisense oligonucleotide' to an appropriate `sense' messenger RNA (mrna) has stimulated considerable interest in the potential use of these materials as therapeutic agents. 1 Due to a number of well-documented limitations, naturally occurring phosphodiester-linked nucleic acids (DNA and RNA 1, Fig. 1) are not suitable drug candidate molecules. One of their main limitations is their instability towards a number of nuclease enzymes. Many attempts have been made to increase nuclease resistance by chemical modi cation of the oligonucleotide backbone, 1,2 and we have recently reported our own work in this area. 3 In particular we have been interested in the synthesis of nucleotides possessing a vinylphosphonate internucleotide linkage 4 and we were able to show that a thymidine dimer possessing this backbone modi cation could be synthesised using a palladium catalysed carbon±phosphorous coupling as a key step (Fig. 1). 3,5 Using tetrakis(triphenylphosphine)- palladium(0) as catalyst, triethylamine as base and DMF as the solvent, we were able to obtain the modi ed dimer 4 in a pleasing 42% yield. In this letter we now wish to describe further studies in this area which have led to the development of a new coupling protocol and the synthesis of a new range of interesting modi ed nucleotide dimers. Although we were pleased at the initial 42% yield for this coupling, we realised that it needed to be improved upon if we were going to have a feasible route to modi ed oligonucleic acids. * Corresponding author. Tel: (0115) 951 3045; fax: (0115) 951 3564; e-mail: chris.hayes@nottingham.ac.uk 0040-4039/00/$ - see front matter # 2000 Elsevier Science Ltd. All rights reserved. PII: S0040-4039(00)00653-5

4514 Figure 1. Upon examining the composition of the mass balance of the reaction it was obvious that the major by-product formed was the secondary alcohol 5. The formation of 5 can easily be accounted for by the hydrolysis of the H-phosphonate coupling partner 2. Control reactions quickly con rmed this hypothesis, as 2 was hydolysed to 5 in quantitative yield by treatment with triethylamine in DMF at room temperature in less than one hour. This result was slightly concerning as it appeared that decomposition of the H-phosphonate coupling partner was a rather facile process under the coupling reaction conditions. In order to address this potentially serious problem we needed to either stabilise the H-phosphonate towards hydrolysis or improve the rate of the coupling reaction. Ideally we hoped to nd conditions to achieve both of these goals, but we rst decided to address the problem of increasing the rate of coupling step. Over the last few years there have been massive improvements in the area of transition metal-catalysed amine arylation reactions. 6 It has been found that sterically demanding and/or chelating ligands are especially good in this type of transformation. Due to the obvious similarities between this and our carbon± phosphorous coupling reaction, we wondered whether analogous changes to our catalyst would result in a useful rate enhancement. We therefore decided to examine the use of the catalyst generated in situ from commercially available 1,1 0 -bis(diphenylphosphino)ferrocene (dppf) and palladium acetate in re uxing THF. Rather gratifyingly, we found that this combination of catalyst and solvent resulted in the formation of the coupled product 4 in a much improved 78% yield. Changing the ligand to dppf and solvent to THF also resulted in an unexpected simpli cation of the isolation and puri cation procedure. After the reaction was judged complete by TLC analysis, the volatiles were removed in vacuo and the crude residue was subjected to puri cation by ash column chromatography. When PPh 3 was used as ligand, the puri cation of 4 was rather laborious, as it was often contaminated with the almost co-polar triphenylphosphine oxide. The use of dppf as ligand completely removed this inconvenience, and 4 could be isolated in pure form from the initial isolation and puri cation procedure. With this success in hand we now wanted to test the scope and limitations of this catalyst system. In order to do this we rst needed to synthesise a range of additional H-phosphonate coupling partners. The H-phosphonates 8a±c were synthesised from the alcohol 5, via the phosphoramidites 7a±c, using standard procedures (Scheme 1). 7 We were now in a position to examine the palladium-catalysed couplings of 8a±c with the vinyl bromide 3. Firstly, 8a and 8b were coupled using the newly developed dppf/thf catalyst system (the cyanoethanol-protected H-phosphonate 11 was not subjected to these reaction conditions due to its sensitivity to amine bases). In both cases we were able to isolate the desired coupled products 9 and 10, albeit in rather modest yields (21% and 24%, respectively, Fig. 2). We were

4515 Scheme 1. somewhat disappointed with these results, especially since we were using the `improved' catalyst system. Once again we isolated signi cant amounts of the hydrolysis product 5 from the reaction mixtures, and it seemed that the rate of coupling was slower than the rate of decomposition for the more hindered H-phosphonates 8a and 8b. To overcome this problem we next examined the use of an alternative HBr scavenger to replace the triethylamine. The use of propylene oxide for this purpose has been reported previously in the synthesis of arylphosphonates and phosphinates, 8 and this looked ideal for our purposes. We therefore repeated the coupling reactions of 8a and 8b with 3, using 1.2 equivalents of propylene oxide in place of the 4.5 equivalents of triethylamine. To our pleasure this resulted in increased yields of the desired coupled products 9 and 10 (53% and 65%, respectively). Having eliminated the need for amine base in the reaction conditions, we could now examine the coupling of 8c without fearing removal of the cyanoethyl protecting group. Thus, 8c was coupled with 3 using the new coupling conditions (Pd(OAc) 2, dppf, THF, propylene oxide (1.2 equiv.), re ux) to yield the desired dimer 11 in excellent yield (72%). Figure 2. Conditions: (a) Pd(OAc) 2, dppf, THF,,20h,Et 3 N (4.5 equiv.); (b) Pd(OAc) 2, dppf, THF,, 20 h, propylene oxide (1.2 equiv.) These results indicate that the dppf/thf/propylene oxide coupling conditions are well suited to a fairly wide range of H-phosphonate coupling partners. Although we were very pleased with these ndings, we were acutely aware that if this methodology was to nd any use in synthesising

4516 biologically important modi ed nucleic acid sequences we would have to be able to access materials containing purine as well as pyrimidine bases. As a preliminary study in this area we synthesised the N-benzoyl-protected H-phosphonate 12 to act as a purine-containing coupling partner. 9 We were delighted to nd that coupling of 12 with 3, using the latest evolution of our coupling conditions (vide supra), gave the desired N-protected AT dimer 13 in an excellent 92% yield (Scheme 2). Scheme 2. In summary, we have developed a convenient coupling strategy to allow rapid access to a range of backbone modi ed nucleic acids. The conditions outlined above seem to have some degree of generality and are tolerant of a number of potentially sensitive functional groups. We have also demonstrated for the rst time that a mixed purine±pyrimidine sequence can be synthesised in high yield. We are currently developing this methodology further, and examining the chemistry necessary to incorporate these modi ed dimers into oligonucleotide sequences. The results of these studies will be reported in due course. Acknowledgements We would like to thank the Nu eld Foundation (NUF-NAL) and the School of Chemistry, University of Nottingham for nancial support and The University of Nottingham for the provision of a Ph.D. studentship (SA). References 1. (a) Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543; (b) Szymkowski, D. E. Drug Discovery Today 1996, 1, 415; (c) Englisch, U.; Gauss, D. H. Angew. Chem., Int. Ed. Engl. 1991, 30, 613. 2. (a) Of the more recent modi cations, the protein nucleic acids (PNAs) are worthy of special note. For a comprehensive review, see: Uhlmann, E.; Peyman, A.; Breipohl, G.; Will, D. W. Angew. Chem., Int. Ed. Engl. 1998, 37, 2797; (b) The rst `antisense oligonucleotide' therapeutic (Vitravene TM ), based upon a phosphorothioate internucleotide linkage, was approved by the FDA in August 1998 for treatment of CMV retinitis (for more details please see the Isis pharmaceuticals web site at www.isip.com).

3. Abbas, S.; Hayes, C. J. Synlett 1999, 1124. 4. See also: Zhao, Z.; Caruthers, M. H. Tetrahedron Lett. 1996, 37, 6239. 5. Hirao, T.; Masunaga, T.; Yamada, N.; Ohshiro, Y.; Agawa, T. Bull. Chem. Soc. Jpn. 1982, 55, 909. 6. (a) Hammann, B. C.; Hartwig, J. F. J. Am. Chem. Soc. 1998, 120, 7369; (b) Harris, M. C.; Geis, O.; Buchwald, S. L. J. Org. Chem. 1999, 64, 6019 and references cited therein. 7. (a) Fukase, K.; Yoshimura, T.; Kotani, S.; Kusumoto, S. Bull. Chem. Soc. Jpn. 1994, 67, 473; (b) Tanaka, T.; Tamatsukuri, S.; Ikehara, M. Tetrahedron Lett. 1986, 27, 199; (c) Marugg, J. E.; Burik, A.; Tromp, M.; van der Marel, G. A.; van Boom, J. H. Tetrahedron Lett. 1986, 27, 2271 and references cited therein. 8. Lei, H.; Stoakes, M. S.; Schwabacher, A. W. Synthesis 1992, 1255. 9. The H-phosphonate 12 was synthesised in a similar manner to the H-phosphonate 2, which we have reported previously. The synthesis involves selective TBS-5 0 -protection of commercially available N-benzoyl-2 0 -deoxyadenosine, coupling with N,N-diisopropylmethylphosphonamidic chloride and then tetrazole-mediated hydrolysis in methylene chloride. 4517